|
GB9919413D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
AU7962200A
(en)
*
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
JP4073786B2
(ja)
*
|
2001-04-16 |
2008-04-09 |
田辺三菱製薬株式会社 |
高コンダクタンス型カルシウム感受性ｋチャネル開口薬
|
|
MXPA04001258A
(es)
|
2001-08-10 |
2005-06-06 |
Nippon Chemiphar Co |
Activador para el receptor d que responde al proliferador de peroxisoma.
|
|
DE60232739D1
(de)
|
2001-10-12 |
2009-08-06 |
Nippon Chemiphar Co |
Aktivator des peroxisomproliferator-aktivierten rezeptors delta
|
|
CA2573185A1
(en)
*
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
RU2403240C2
(ru)
*
|
2004-10-12 |
2010-11-10 |
Декод Дженетикс Ехф |
Сульфонамидные пери-замещенные бициклы для лечения окклюзионного поражения артерий
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
AU2007214434B2
(en)
*
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
RU2435764C2
(ru)
|
2006-04-18 |
2011-12-10 |
Ниппон Кемифар Ко., Лтд. |
АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
CN101490045A
(zh)
*
|
2006-05-16 |
2009-07-22 |
解码遗传Ehf公司 |
7-(丙烯酰基)吲哚的制备方法
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
CA2674946A1
(en)
*
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
AU2009236877B2
(en)
|
2008-04-15 |
2014-01-23 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
NZ705058A
(en)
|
2010-03-12 |
2016-10-28 |
Omeros Corp |
Pde10 inhibitors and related compositions and methods
|
|
EP2655362A1
(en)
|
2010-12-22 |
2013-10-30 |
Abbvie Inc. |
Hepatitis c inhibitors and uses thereof
|
|
AU2014220801A1
(en)
|
2013-02-21 |
2015-09-10 |
Adverio Pharma Gmbh |
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
NZ716462A
(en)
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
CA2959501C
(en)
|
2014-08-29 |
2023-10-10 |
Chdi Foundation, Inc. |
Probes for imaging huntingtin protein
|
|
CN107530313A
(zh)
|
2015-04-24 |
2018-01-02 |
奥默罗斯公司 |
Pde10抑制剂以及相关组合物和方法
|
|
CA3003611C
(en)
|
2015-11-04 |
2022-11-01 |
Omeros Corporation |
Solid state forms of a pde10 inhibitor
|
|
JP7006990B2
(ja)
|
2017-11-17 |
2022-02-10 |
セリックス バイオ プライヴェート リミテッド |
眼障害の処置のための組成物及び方法
|